|
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents Clinical research trials and T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents. T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents clinical trial. Participants frequently get the best healthcare available for their T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents  T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
For Condition: HIV Infections
Status: No longer recruiting
Sponsor(s): Hoffmann-La Roche , Trimeris
Synopsis: This study will evaluate T-20 in children.
Details: Children are stratified by age group (3 through 11 years and 12 through 16 years). Samples for HIV-1 genotype and phenotype resistance testing are obtained at screening to aid in the selection of concomitant antiretrovirals. Simultaneous to initiating T-20, all patients begin a "new" optimized antiretroviral regimen based on the patients' prior treatment history, historical resistance testing results, and the results of the testing performed at screening. Patients are followed for safety and other assessments at Weeks 1, 2, and 4, then monthly through Week 24 and bimonthly through Week 48. Pharmacokinetic sampling at selected study visits are performed.
Eligibility:
Study Type: Interventional, Treatment, Safety Study
Minimum Age/Maximum Age: 3 Years/16 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients may be eligible for this study if they: - Are 3 through 16 years of age and have the consent of parent or guardian. - Have a viral load of at least 5000 copies/ml. - Have taken at least 2 of the 3 licensed anti-HIV drug classes for at least 3 months. - Have been on stable therapy for at least 4 weeks.
Total Enrollment: 48
Location and Contact Information:
Mount Sinai Hosp
New York City, New York, 10029
United States
Children's Hosp Los Angeles
Los Angeles, California, 90027
United States
Bronx Municipal Hosp Ctr/Jacobi Med Ctr
Bronx, New York, 10461
United States
Bronx Lebanon Hosp Ctr
Bronx, New York, 10457
United States
New York Hosp - Cornell / Program for Children with AIDS
New York City, New York, 10021
United States
Univ of Florida Gainesville
Gainesville, Florida, 32610
United States
Children's Hosp of the King's Daughters
Norfolk, Virginia, 23507
United States
Additional Information:
Study ID Numbers: 295E; T20-310
Study Start Date:
Record last reviewed: May 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00022763
Other Hiv Infections Studies:
1. A Study of T-20 in HIV-Positive Adults
2. A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success with Amphotericin B
3. A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination with Soluble Recombinant Envelope Vaccine (VaxSyn)
4. Psychosocial Correlates and Coping Strategies Associated with Long-Term Survival of HIV-Infected Children
5. A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
Related Studies:
Other HIV Infections Clinical Trials
Other Virginia Clinical Trials
Other Norfolk Clinical Trials
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
|
|
|
|
|
|
|
|
